𝗕𝗲𝘀𝘁 𝗣𝗿𝗮𝗰𝘁𝗶𝗰𝗲𝘀 & 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 – 𝗧𝗵𝘂𝗿𝘀𝗱𝗮𝘆 𝟱𝘁𝗵 𝗠𝗮𝗿𝗰𝗵
EPiC is pleased to highlight an upcoming webinar hosted by the Research Quality Association (RQA), designed for professionals involved in clinical trial operations, IMP oversight, and regulatory compliance.
This comprehensive session will guide delegates through the full lifecycle of Investigational Medicinal Products (IMPs) , from early trial planning through to patient administration and final destruction. Participants will gain clarity on regulatory expectations, real‑world application, and how to avoid the common causes of non-compliance.
What the Webinar Will Cover
The training will explore the end‑to‑end IMP journey, including:
- Protocol and Clinical Trial Authorisation (CTA) requirements
- Sourcing and managing IMP supply
- Manufacturing, packaging, and labelling considerations
- Storage, transport, and distribution obligations
- Site responsibilities: administration, accountability, and reconciliation
- IMP returns and destruction
The webinar will be delivered by two highly experienced experts, Mark Poulton and EPiC’s Operations Manager Michelle Yeomans, Former MHRA inspectors specialising in GCP and GMP, both bring extensive regulatory and industry insight that will benefit delegates at all experience levels.
Event Details
Date: Virtual, Online webinar- Thursday 5th March 2026
This session is ideal for anyone responsible for clinical trial conduct, IMP management, or quality oversight. Early booking is recommended.